Finance

Lists
BWAY:NASDAQ
Brainsway Ltd - ADR
$14.92
-1.65%
(-0.25) 1D
Aug 20, 3:11:14 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BWAY...
Open
$15.16
High
$15.33
Low
$14.84
Mkt. cap
593.92M
Avg. vol.
150.11K
Volume
37.13K
P/E ratio
39.62
52-wk high
$17.40
52-wk low
$7.14
EPS
$0.38
Beta
1.24
Shares outstanding
40.19M
No. of employees
129
Open
$15.16
High
$15.33
Low
$14.84
Mkt. cap
593.92M
Avg. vol.
150.11K
Volume
37.13K
P/E ratio
39.62
52-wk high
$17.40
52-wk low
$7.14
EPS
$0.38
Beta
1.24
Shares outstanding
40.19M
No. of employees
129
News stories
From web sources and news partners
Profile
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem. Wikipedia
About Brainsway Ltd - ADR
CEOHadar Levy | Christopher von Jako
Employees129
Founded2003
HeadquartersJerusalem, Jerusalem District, Israel
SectorMedical device
Websitebrainsway.com
Analyst ratings
Based on 2 analysts giving stock ratings to BWAY in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for BWAY in the last 3 months.
Highest
Current $14.92
$18.00 (+20.64%)
Average
$17.50 (+17.29%)
Lowest
$17.00 (+13.94%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$17.00
+13.9%
07/24/2026
Sam Eiber
BTIG
Buy
Initiated
$18.00
+20.6%
07/20/2026
Carl Byrnes
Northland Securities
Buy
Maintained
$15.00
+0.5%
01/22/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
$9.50
-36.3%
11/12/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.51M
14.54M
15.53M
17.11M
Cost of goods sold
3.35M
3.43M
3.86M
4.34M
Cost of revenue
3.35M
3.43M
3.86M
4.34M
Research and development expenses
2.40M
2.53M
2.88M
3.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.51M
6.67M
6.79M
7.16M
Operating expense
8.91M
9.20M
9.67M
10.38M
Total operating expenses
12.26M
12.63M
13.53M
14.72M
Operating income
1.25M
1.92M
2.00M
2.39M
Other non operating income
-
2.52M
-
-
EBT including unusual items
1.81M
2.54M
2.41M
2.92M
EBT excluding unusual items
1.81M
2.54M
2.41M
2.92M
Income tax expense
242.00K
-334.00K
120.00K
208.00K
Effective tax rate
13.38%
-13.14%
4.98%
7.13%
Other operating expenses
-
-
-
-
Net income
1.57M
2.88M
2.29M
2.71M
Net profit margin
11.59%
19.77%
14.74%
15.84%
Earnings per share
0.02
0.06
0.06
0.07
Interest and investment income
1.13M
216.00K
724.00K
1.41M
Interest expense
-571.00K
-1.53M
-319.00K
-879.00K
Net interest expenses
555.00K
-1.32M
405.00K
527.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
1.66M
2.27M
2.47M
2.83M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps